UiPath

PATH

Market cap $6.23B

Zebra Technology's stock is up more than 11% this year. UiPath has shown it can be profitable.

UiPath is rated a buy at $12, trading at 15x FY2027 and 13x FY2028 earnings, with strong 80%+ gross margins. Revenue grew 17% to $418M in Q1 FY2027, ARR rose 12% to $1.9B, and non-GAAP operating margin reached 22%. Agentic automation (Maestro) is UiPath's key catalyst, but AI monetization is unproven; net retention at 109% needs to improve for higher growth.

Short‑interest screens are lighting up with a tight cluster of mid‑ and large‑cap names where bearish bets have gone all‑in, turning these stocks into live‑wire squeeze candidates rather than sleepy laggards.

PATH's six-month pullback comes as AI adoption, enterprise customer growth and profitability improve, creating a more attractive entry point.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

In the closing of the recent trading day, UiPath (PATH) stood at $11.68, denoting a -1.02% move from the preceding trading day.

PATH's pullback has lowered its valuation as improving profitability, ARR growth and an upbeat outlook strengthen the long-term investment case.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

IonQ is a leader in the race toward accurate quantum computing. SoundHound AI's acquisition of LivePerson could be a game changer.

Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.